SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Onesource Specialty Pharma submits analyst meet intimation

21 Jul 2026 Evaluate
Onesource Specialty Pharma has informed that the Company has scheduled its Earnings Call with analysts/ investors on Saturday, July 25, 2026, at 10:00 hrs IST to discuss the unaudited financial results of the Company for the quarter ended June 30, 2026. Earnings Call details are enclosed for ready reference.

The above information is a part of company’s filings submitted to BSE.

Onesource Specialty Share Price

1673.80 25.40 (1.54%)
22-Jul-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1942.95
Dr. Reddys Labs. 1183.00
Cipla 1415.10
Lupin 2405.80
Zydus Lifesciences 1129.75
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: